Market Tracker

05/24 1:48pm ET

Actavis Inc (NYSE:ACT)

127.01
Real-Time Quote
 -1.07 / -0.84%
Today’s Change
67.67
Today|||52-Week Range
133.00
+47.69%
Year-to-Date

Today’s Trading

Previous close128.08
Today’s open127.90
Day’s range125.95 - 128.12
Volume1,247,550
Average volume (3 months)1,574,202
Market cap$17.1B
Dividend yield--
Data as of 1:48pm ET, 05/24/2013

Growth & Valuation

Earnings growth (last year)-63.11%
Earnings growth (this year)+38.86%
Earnings growth (next 5 years)+11.15%
Revenue growth (last year)+29.02%
P/E ratioNM
Price/Sales1.83
Price/Book4.27

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-0.25-0.32%
ZTSZoetis Inc+0.51+1.55%
SHPGShire PLC+2.59+2.68%
ALXNAlexion Pharmaceutic...-1.04-1.04%
Data as of 1:48pm ET, 05/24/2013

Financials

Next reporting dateJuly 31, 2013
EPS forecast (this quarter)$2.00
Annual revenue (last year)$5.9B
Annual profit (last year)$97.3M
Net profit margin1.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Global Chief Financial Offi
cer
R. Todd Joyce, CPA
Corporate headquarters
Parsippany, New Jersey

Forecasts